AstraZeneca reports CLL trial success with Calquence combo
AstraZeneca PLC (LSE/STO/Nasdaq: LON:) today announced positive results from its Phase III AMPLIFY trial, demonstrating...
Blog
Eledon Provides Enrollment Update for Phase 2 BESTOW Trial Assessing Tegoprubart for the Prevention of Organ Rejection
80 Participants (Two-thirds of Projected Recruitment) Enrolled IRVINE, Calif., July 29, 2024 (GLOBE NEWSWIRE) —...
McDONALD’S REPORTS SECOND QUARTER 2024 RESULTS
Consolidated revenues for the quarter were nearly $6.5 billion, an increase over prior year of...
Acumen Pharmaceuticals Announces First Subject Dosed in Phase 1 Study of Subcutaneous Sabirnetug (ACU193) for Early Alzheimer’s Disease
NEWTON, Mass., July 29, 2024 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage...
Enstar Pref D stock hits 52-week low at $21.94 amid market shifts
In a challenging economic climate, Enstar Group Limited’s Preferred Shares Series D (ESGRP) touched a...
Surging yen upends popular global FX carry trades
By Alun John, Harry Robertson and Tom Westbrook LONDON/SINGAPORE (Reuters) – A perfect storm of...
Emerson’s Transformative GenAI Automation Delivers Powerful New Tool for Power and Water Industries
Ovation Automation Platform with GenAI will empower workforce, optimize operations PITTSBURGH, July 29, 2024 /PRNewswire/...
Sainz to join Williams from 2025 after Ferrari exit
Ferrari driver Carlos Sainz is to join Williams next season on what the team calls a “multi-year” contract.
Canada appeal against points deduction but not ban
Canada launch an appeal after having six points deducted in the Olympic women's football competition but no appeal against coach ban.
